USPTO trademark

CELLGORITHM

Under examinationUSPTOWord markClass 1Class 5Class 9

"CELLGORITHM" is a word mark owned by Syntax Bio, Inc., filed at the USPTO on April 8, 2026. It is under examination and covers classes 1, 5 and 9.

Get this data via the API
Official USPTO record
CELLGORITHM trademark as filed
As filed with the USPTO
Status
Under examination
Since August 21, 2026
Filed
April 8, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99752458
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns CELLGORITHM

The owner and representative on file with the office.

Owner

Syntax Bio, Inc.

Chicago, United States

Representative

Christina L. Martini

Dechert LLP

Goods and services

What the mark covers

The products and services CELLGORITHM is filed for, grouped by Nice class.

  • Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; differentiated or terminal cells for research and scientific purposes; lineage specific progenitor cells for research and scientific purposes; organoids for research and scientific purposes; organoids for drug screening; multi-cell type organoid engineering; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use

  • Pharmaceuticals in the nature of cell therapeutics and organoid therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells or organoids for medical or clinical use; cells or organoids which are propagated, cultivated and expanded in bioreactors for medical or clinical use; cells or organoids for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells or organoids for medical use; diagnostic preparations for medical and veterinary purposes; cell or organoid preparations for medical use in drug screening; cell or organoid preparations for genetic testing and screening for clinical and medical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies and reagents for medical and diagnostic or clinical use; tissue culture media growth factors in the nature of cell growth, cell growth media and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells all for medical and clinical use; cell separation reagents for medical and clinical use

  • Downloadable and recorded computer software, artificial intelligence, machine learning methods, and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software program, artificial intelligence, machine learning methods, for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and control laboratory biomanufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of non-final action e-mailed
  2. Non-final action e-mailed
  3. Non-final action written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About CELLGORITHM

Who owns the trademark "CELLGORITHM"?

The USPTO trademark "CELLGORITHM" (application 99752458) is owned by Syntax Bio, Inc.

What is the status of "CELLGORITHM"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CELLGORITHM and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d7a2e-eb92-737d-bf09-ff2f27bf0aed
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d7a2e-eb92-737d-bf09-ff2f27bf0aed",
  "object": "trademark",
  "mark_text": "CELLGORITHM",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99752458",
  "filing_date": "2026-04-08",
  "nice_classes": [
    1,
    5,
    9
  ],
  "owners": [
    {
      "name": "Syntax Bio, Inc.",
      "entity_id": null
    }
  ]
}